10 Years Venture Kick Ceremony | MaxWell Biosystems is a Global Shaper

MaxWell Biosystems joined the celebration of Venture Kick’s 10-year anniversary last 29 November 2017. Held in Schlieren, the ceremony welcomed 500 guests–all involved in the Swiss innovation, entrepreneurship, and investment community. Venture Kick included a variety of events during the evening, such as a startup exhibition, speeches, guitar concert, and a fashion show. Everyone enjoyed the sumptuous dinner, desserts, and drinks. Global Shapers Venture Kick nominated high-impact startups for each of the ten years since the program started. The Global…

MaxWell Biosystems at European Retina Meeting 2017

From October 5th to the 7th, MaxWell Biosystems hosted a booth at the European Retina Meeting, in Paris, France. The conference attracted retina experts, researchers, and students. Paris was a great host, and MaxWell Biosystems even had the opportunity to attend a gala dinner in the city. MaxWell Biosystems would like to thank the organizers for a job well done!   Conference attendees loved the levitating MaxOne chip on display. Additionally, ERM 2017 gave MaxWell Biosystems the opportunity to debut the brand new Tissue Holder, specifically made for retinal applications.   We’re excited to…

MaxWell Biosystems at iForum 2017 in London

On September 28, 2017, MaxWell Biosystems’ VP of Scientific Affairs, Michele Fiscella, travelled to London to meet with stem cell researchers from academia, and the pharma and biotech industries. Michele presented results from using the MaxOne platform with induced pluripotent stem cells (iPSCs) in a presentation titled, “High-resolution microelectrode array platform for biomarker discovery and novel functional assays with human iPSC-derived neurons.”   After presenting promising results and receiving a positive reception from researchers at iForum, Michele is excited about the potential for using MaxWell Biosystems’…

MaxWell Biosystems technology in “The Secrets of Vision”

MaxWell Biosystems was excited to see Dr. Michele Fiscella, VP Scientific Affairs, featured in “The Secrets of Vision”. Michele discussed the state of vision disease research. The video is part of a film series produced by Systems X, the Swiss Initiative in Systems Biology. “The Secrets of Vision” tracks the increasing importance of research on vision-related diseases — with the end goal of developing effective drugs and treatment. In the feature, Michele explains how high-density microelectrode array systems, such as MaxOne, can accelerate this type of retinal cell research. He comments, “High…

MaxWell Biosystems recognized in Top 100 Swiss Startups 2017

“Top 100 Swiss Startup Award,” September 6, 2017 MaxWell Biosystems is honored to be recognized as one of the Top 100 Swiss startups of 2017! The list is published each year by IFJ and startup.ch and all of the best Swiss startups are included. CEO Urs Frey and CTO Jan Muller attended the awards ceremony in Zurich.   See MaxWell Biosystems and all of the Top 100 startups in Startup Ticker’s Official News Release >>

MaxWell Biosystems Featured at ETH Industry Day 2017

ETH Industry Day, August 29, 2017 With 600 attendees, ranging from ETH researchers to industry experts, ETH Industry Day 2017 brought together the research and industry community to inspire attendees about the current stage of research and technology at ETH. As a spin-off that is successfully bringing technology from academia into industry, MaxWell Biosystems was proud to present. The event was a great opportunity to network with leaders, researchers, and industry members from the ETH community. It was exciting to start discussions across many…

MaxWell Biosystems at the 2017 ISN-ESN Meeting in Paris

From August 20 to 24th, MaxWell Biosystems exhibited a booth at the 2017 Biennial Meeting of the International Society of Neurochemistry in Paris, France. CEO, Dr. Urs Frey, and Dr. Michele Fiscella were excited to discuss how the MaxOne high-resolution electrophysiology platform can be used for applications in neurochemistry with conference attendees. MaxWell Biosystems looks forward to connecting with neurochemistry researchers interested in using MaxOne and MaxTwo for their research.  

MaxWell Biosystems at the Annual Meeting of the Japanese Neuroscience Society (JNS) 2017

MaxWell Biosystems travelled to Chiba, Japan and exhibited at the 40th Annual Meeting of the Japanese Neuroscience Society from July 20th to 23rd. CEO, Dr. Urs Frey, and Dr. Marie Obien were excited to show off both the MaxOne and MaxTwo systems at this year’s Japanese neuroscience conference focused on “Pushing the Boundaries of Neuroscience.” MaxWell Biosystems received a warm reception from the Japanese neuroscience community, and we look forward to connecting with researchers excited about using the MaxOne and MaxTwo. We will return to the conference next year in…

MaxWell Biosystems at ISSCR2017 Annual Meeting

MaxWell Biosystems had a great time at the ISSCR2017 Annual Meeting in Boston. The conference was held on the 14th to 17th of June at the Boston Convention and Exhibition Center. The ISSCR annual meeting brought together stem cell researchers from all over the world  aiming to create strong research networks and new opportunities to push forward the research about degenerative and rare diseases. One of the highlights of the meeting was the talk of Prof. Dr. Shinya Yamanaka, who received a Nobel Prize…

MaxWell Biosystems at venture leaders Life Science 2017 in Boston

From the 12th to the 16th of June MaxWell Biosystems and other nine Swiss Life Science startups participated in the business-boosting venture leaders Life Science program, held in Boston. It was an inspiring week, co-organized by swissnex Boston, with pitching events, company visits, and meetings with VCs and experts. Indeed, it was a great opportunity for the ten selected startups to take the first steps towards global expansion. The ten startups met medtech and biotech industry experts who gave motivating feedback on different aspects of business development. The…

MaxWell Biosystems wins Venture Kick

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

MaxWell Biosystems featured in ETH News

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

MaxWell Biosystems at Startup Champions Seed Night

  MaxWell Biosystems participated at the startup presentation event  “Startup Champions Seed Night” on the 26th of April in the Rolex Learning Center Forum in EPFL. The event was co-organized by EPFL Alumni, the Innogrants and venturelab. A nice audience of 400 people attended the event.

MaxWell Biosystems as a nominee for De Vigier Award 2017

MaxWell Biosystems was successfully preselected as one of the 10 nominees for the W. A. De Vigier Stiftung award. The Award Ceremony will take place in Solothurn on the 18th of May 2017. The William A. De Vigier foundation provides assistance to young Switzerland entrepreneurs. Since its 28th anniversary, the foundation has distributed over 10 million francs of start-up capital.

MaxWell Biosystems at BNA 2017 Festival of Neuroscience

MaxWell Biosystems exhibited MaxOne at the BNA 2017 Festival of Neuroscience on April 10-13, 2017 at the ICC, Birmingham. BNA 2017 is one of the largest neuroscience conferences in Europe this year organized by the British Neuroscience Association. Our MaxOne high-resolution technology attracted a lot of interest. And this is not just because of our magic levitation device, but much more because it allows to monitor neuronal activity at various scales, from full networks, to single-cell activity and even subcellular features. We…

MaxWell Biosystems selected for the Venture Leaders Life Sciences 2017 Team (Boston)

After a competitive process, MaxWell Biosystems has been selected as one of the ten members of the Venture Leaders Life Sciences 2017 team. Ten new Swiss innovative start-ups will take part in a startup development program in Boston, Massachusetts on June 11-17, 2017. This “business boosting” week, co-organized by venturelab and swissnex Boston, will enable the selected swiss startups to take the first steps towards their global expansion.      

MaxWell Biosystems at DPG 2017

MaxWell Biosystems presented MaxOne at the 96th annual meeting of the Deutsche Physiologische Gesellschaft in Greifswald, Germany on March 16-18, 2017. The German Physiology Society meeting was held at one of the oldest universities in Germany, University of Greifswald (founded 1456). The meeting was participated by researchers working on diverse areas of physiology, including cardiac cell physiology and cellular neuroscience.

MaxWell Biosystems in Cambridge, UK

MaxWell Biosystems exhibited MaxOne with its newly developed data acquisition unit at the SelectBio Advances in Drug Discovery Conference in Hinxton, Cambridge, UK. It was an exciting meeting, attended by many researchers who are currently screening for efficacy and toxicity using iPS cell lines or developing enabling techniques and technologies for this. Progress in stem cell biology is revolutionizing drug discovery research now; the ability to grow and differentiate stem cell lines is providing a far more relevant model for…

Retina study utilizing HD-MEAs (MaxOne) selected as “Best of Neuron”

The paper by K. Yonehara*, M. Fiscella*, A. Drinnenberg*, et al. entitled “Congenital Nystagmus Gene FRMD7 is necessary for establishing a neuronal circuit asymmetry for direction selectivity” was chosen for the “Best of Neuron” selection 2015-2016. “Best of Neuron“ includes ground-breaking neuroscience research published in Neuron and is a collection of editors’ and readers’ favorites. MaxWell Biosystems HD-MEA core technology was used in this study, to characterize the disease phenotype discovered in the FRMD7 mutant retina. Mutation in the FRMD7 gene is linked to the…

MaxWell Biosystems wins CHF 20,000 at Venture Kick (Stage 2)

MaxWell Biosystems successfully cleared Venture Kick Stage 2 and received CHF 20,000. See Venture Kick news here >> Venture Kick finances start-ups at the early stage with a grant of up to CHF 130,000 and provides professional support of business experts.
Twitter Updates
Contacts








Mattenstrasse 26
4058 Basel, Switzerland

+41 61 551 10 70

+41 61 551 10 71

info@mxwbio.com